GLYCOMIMETICS Trademark

Trademark Overview

On Thursday, August 29, 2013, a trademark application was filed for GLYCOMIMETICS with the United States Patent and Trademark Office. The USPTO has given the GLYCOMIMETICS trademark a serial number of 86051401. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, September 5, 2025. This trademark is owned by Glycomimetics, Inc.. The GLYCOMIMETICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
glycomimetics

General Information

Serial Number86051401
Word MarkGLYCOMIMETICS
Filing DateThursday, August 29, 2013
Status800 - REGISTERED AND RENEWED
Status DateFriday, September 5, 2025
Registration Number4630906
Registration DateTuesday, November 4, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 19, 2014

Trademark Statements

Description of MarkThe mark consists of a hexagon and the word "GLYCOMIMETICS".
Pseudo MarkGLYCO MIMETIC
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"GLYCOMIMETICS"
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 9, 2013
Primary Code042
First Use Anywhere DateFriday, September 30, 2011
First Use In Commerce DateFriday, September 30, 2011

Trademark Owner History

Party NameGlycomimetics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameGlycomimetics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20879
Party NameGlycomimetics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20879

Trademark Events

Event DateEvent Description
Monday, September 2, 2013NEW APPLICATION ENTERED
Monday, September 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 10, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 19, 2013NON-FINAL ACTION E-MAILED
Thursday, December 12, 2013ASSIGNED TO EXAMINER
Thursday, December 19, 2013NON-FINAL ACTION WRITTEN
Thursday, December 19, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 18, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 18, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, June 18, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 18, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, July 15, 2014ASSIGNED TO LIE
Tuesday, August 19, 2014PUBLISHED FOR OPPOSITION
Friday, June 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 16, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 19, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 4, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 13, 2020TEAS SECTION 8 & 15 RECEIVED
Saturday, January 16, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, May 5, 2025TEAS SECTION 8 & 9 RECEIVED
Friday, September 5, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 5, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, September 5, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, September 5, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, November 4, 2014REGISTERED-PRINCIPAL REGISTER
Saturday, January 16, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, January 16, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 4, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

glycomimetics fields biotechnology pharmaceutical development research